pharmaphorum

SEPTEMBER 30, 2022

Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug for another few years. billion in the first half of 2022.

Marketing 59

Marketing Sales Competition FDA 59

European Pharmaceutical Review

JANUARY 31, 2025

By the end of the decade, two cell and gene therapies will be subject to follow-on competition for the first time, beginning a whole new chapter in the biosimilar history. Over time, patient volumes (patient treatment days) and levels of competition, including market share, were also considered. 6 billion in 2024 alone).

Medicine 52

Medicine Competition Marketing Patients 52

Pharmaceutical Technology

FEBRUARY 24, 2023

The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies.

Pharma 64

Pharma Medicine Competition Marketing 64

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Currently, 40 biosimilars are FDA-approved and 25 have launched, whereas the EMA has approved 86 biosimilars since 2006. The biosimilar market in the US may progress differently this time.

Competition 59

Competition Marketing FDA Physicians 59

CloserIQ

OCTOBER 10, 2018

Founded 2006. Founded 2006. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Salsify offers competitive benefits and a flexible vacation plan. Founded 2006. 251-500 employees. in VC funding, $150M raised at IPO. See open roles. 1001-5000 employees.

Sales 76

Sales Management Marketing Education 76

European Pharmaceutical Review

DECEMBER 19, 2022

European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006″ European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006. The Impact of Biosimilar Competition in Europe, IQVIA, December 2021.

Medicine 52

Medicine Biopharma Safety Food 52

Pharmaceutical Technology

OCTOBER 5, 2022

However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape. However, Biogen was able to bring Tysabri back to the market in 2006, after providing evidence that the benefits of the drug outweighed its risk.

Government 59

Government Specialization Physicians Marketing 59

Clarivate

APRIL 24, 2023

The drug store entered the retail clinic business in summer 2006 by acquiring Minneapolis-based MinuteClinic, an already-established chain of retail-based healthcare clinics with many locations inside CVS pharmacies. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Healthcare Success

JULY 5, 2022

Editor’s Note: I wrote the first version of this blog post back in 2006 when we launched Healthcare Success. How to create marketing and lead generation systems that get results. By Stewart Gandolf, MBA. While I intentionally wrote it with a quick, playful tone, more than sixteen years later, it remains one of our most popular posts.

Doctors 55

Doctors Physicians Marketing Healthcare 55

eMediWrite

AUGUST 30, 2023

SMEs are also at a disadvantage when compared to their larger counterparts due to delayed payments, which limits their capacity for effective market competition. To ensure prompt payments to MSMEs, strict implementation of current legislation is required, such as the Micro, Small, and Medium Enterprises Development (MSMED) Act, 2006.

Pharma 52

Pharma Government Pharmaceutical Electronics 52

European Pharmaceutical Review

FEBRUARY 22, 2023

1,7 It may depend on the competition between 6 Li and 7 Li, present at much higher concentration, to be ionised. Using molecular recognition of β-cyclodextrin to determine molecular weights of low-molecular-weight explosives by MALDI-TOF mass spectrometry, J Am Soc Mass Spectrom , 2006, 17, 189–193. percent and 7.5=

Food 98

Food Electronics Pharmaceutical Medical 98

Healthcare Success

NOVEMBER 17, 2023

The healthcare industry is evolving, too, so it’s crucial to stay ahead of emerging trends—like the rise of healthcare consumerism and the intrinsic value of creating a positive patient experience—or risk falling behind your competition. Today’s healthcare businesses face new and aggressive competition on multiple fronts.

Healthcare 68

Healthcare Healthcare Marketing Media 68

Pharmaceutical Technology

JULY 10, 2008

The past Global figures from PwC show that in 2006 only two big pharmaceutical companies earned more than 10% of their revenues from major products that were less than three years old. “In 2006 only two big pharmaceutical companies earned more than 10% of their revenues from major products that were less than three years old.”

Food and Drug Administration 40

Food and Drug Administration Medicine Pharmaceutical Medical 40

Healthcare Success

JULY 18, 2022

The healthcare industry is constantly evolving, and it’s essential for all healthcare businesses—and their websites—to evolve to stay competitive. Likewise, to stay relevant in the face of constant change, our agency's business model and clientele have changed multiple times since our founding in 2006. General Competitive Analysis.

Healthcare 52

Healthcare Healthcare Competition Marketing 52

Healthcare Success

APRIL 20, 2023

At Healthcare Success, we have been sharing marketing knowledge, tips, and tricks since our agency’s founding in 2006. Here, you’ll find a few of our most timely and popular blogs conveniently organized by marketing topic.

Healthcare 52

Healthcare Healthcare Marketing Media 52

European Pharmaceutical Review

FEBRUARY 7, 2023

Key changes are expected to be proposed in relation to the Community Code on medicinal products, the EMA Regulation 726/2004 (the EU’s general pharmaceuticals legislation), the Orphan Regulation 141/2000 and the Pediatric Regulation 1901/2006.

Medical 117

Medical Government Marketing Medicine 117

Healthcare Success

FEBRUARY 21, 2023

When I first launched Healthcare Success in 2006, I attended Bruce Clay’s SEO training program for expert advice on optimizing my content for maximum online exposure and lead generation. I knew SEO would be essential for reaching my business goals and that doing it correctly from the start would be crucial.

Healthcare 52

Healthcare Healthcare Marketing Engineering 52

Evolve Your Success

JANUARY 10, 2023

I got the invite to go down to headquarters and do a formal interview panel and a great case competition to secure my role. I started in 2006. I remembered back in 2006. We are held after about 45 minutes to 1 hour, sit down conversation and a formal interview. You started in 2007. They were saying the sales rep was dead.

Sales 130

Sales Medical sales Consulting Medical 130

Pharmaceutical Technology

JULY 23, 2008

” Supply and revenue Cancer drugs can plug revenue gaps created by loss of patents in other areas, as Pfizer hopes to do when competition for its cholesterol fighter Lipitor opens up in two years’ time. There’s been a huge change in the market.”

Side effects 40

Side effects Marketing Pharmaceutical Sales 40

Evolve Your Success

JANUARY 23, 2024

In 2006 or even a little bit earlier than that, Joel Matta was a very well-known orthopedic surgeon. Sometimes my competition will take that article and say, “I could plus or minus 10 millimeters.” The Caribbean’s got a little difficult to navigate in. Walk us through the process. How did OrthoGrid spawn? What happened?

Medical sales 130

Medical sales Sales Medical Physicians 130

World of DTC Marketing

JUNE 7, 2021

Retail price increases for widely used brand name prescription drugs consistently exceeded the rate of general inflation between 2006 and 2020. Eight US antitrust bills targeting the pharmaceutical industry have been recently introduced, addressing a gamut of alleged anti-competitive activity. percent over the same period.

Pharma 187

Pharma Retail Prescription Competition 187